Show Notes: In this episode of the Beyond Beauty Podcast, Alec Batis, a seasoned chemist and skincare innovator, shares his journey from working with industry giants to creating his own company, Sweet Chemistry. After a personal experience with scarring, he collaborated with Silk's Bio to develop a skincare line utilizing regenerative peptides from upcycled bone. About Alec: Alec Batis is an accomplished chemist and product innovator, specifically skin tissue regeneration who has spent the past 30+ years bringing some of the world’s most beloved products to market at Shiseido/NARS, L’Oréal Group/Kiehl’s, among others. Alec is continuously pushing the boundaries of what’s possible in skincare and beauty. In previous roles, he has helped raise industry standards in product quality, efficacy, and safety. He also appeared in the 2019 Academy-nominated documentary Toxic Beauty, encouraging the beauty industry to reimagine what ‘clean’ beauty should be. After experiencing post-gastrointestinal surgery scarring, Alec sought out a solution to minimize scarring to the best of his ability and formed a relationship with Xylyx Bio, a regenerative medicine company harnessing systemic physiology into paradigm-shifting tissue and organ repair technologies. Timestamps: Alec Batis' Background (00:00:01) Introduction to Alec Batis' career and expertise in skincare and beauty industry. Alec's Journey and Career Path (00:02:37) Alec Batis' career journey from being a chemist to working in marketing and consulting for major beauty companies. Product Formulation and Differentiation (00:11:55) Explanation of the unique formulation of Sweet Chemistry products and the use of functional levels of ingredients. Pesticide-Free and Microbiome-Friendly Formulation (00:16:19) Discussion about the avoidance of pesticides in skincare products and the importance of maintaining a healthy skin microbiome. Transparency in Skincare Formulation (00:17:41) Alec Batis' perspective on the need for transparency in declaring the composition and percentages of ingredients in skincare products. Xilinx's innovative approach to drug testing (00:20:45) Xilinx's use of extracellular matrix (ECM) from diseased organs to create a more accurate drug testing environment. Controversy around animal testing in Europe (00:23:04) Discussion of the controversy around animal testing and the potential for alternatives like organs on chips. Regeneration of deceased donor organs (00:24:10) Xilinx's successful regeneration of a deceased donor lung and liver, and their potential impact on organ transplantation. Personal use of Xilinx's peptides (00:25:25) Alec's personal use of Xilinx's peptides to aid in scar healing after undergoing surgeries. Product development and delivery mechanism (00:31:24) Alec's development of skincare products and the use of airless packaging for preservation. Transparency in pricing strategy (00:38:06) Discussion of the pricing strategy for the skincare products and the goal to make them more affordable. Importance of understanding skincare ingredients (00:39:24) The importance of understanding the science behind skincare products and the impact on health. Character and integrity in science (00:40:30) The significance of character and integrity in the pursuit of scientific knowledge. The journey of entrepreneurship (00:41:46) Alec's journey into entrepreneurship and the challenges and rewards of creating a unique skincare product. The founder's perspective (00:43:44) The significance of a founder being the primary user and critic of the product for building a successful business. Customer feedback and growth (00:44:25) The personal nature of launching a product, receiving feedback, and the potential for business growth. Future plans and expansion (00:45:34) Sweet Chemistry's current availability and plans for potential expansion into retail partnerships.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related